William D. Carlson
Corporate Officer/Principal presso Harvard Medical School
Profilo
William D.
Carlson was the founder of Thrasos Therapeutics, Inc. (founded in 2003) where he held the title of Chairman-Scientific Advisory.
Dr. Carlson's current job is Assistant Professor at Harvard Medical School.
Dr. Carlson's former job was Director-Cardiovascular Research at Smith Kline & French BV.
Dr. Carlson received a doctorate degree from Yale University and an undergraduate degree from Harvard College.
Dr. Carlson is also the founder of ArQule, Inc...
Posizioni attive di William D. Carlson
| Società | Posizione | Inizio |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - |
Precedenti posizioni note di William D. Carlson
| Società | Posizione | Fine |
|---|---|---|
| ARQULE, INC. | Founder | - |
| Smith Kline & French BV | Corporate Officer/Principal | - |
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Founder | - |
Formazione di William D. Carlson
| Yale University | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
| Smith Kline & French BV | |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
- Borsa valori
- Insiders
- William D. Carlson
